Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease
J Jerábek, Elisa Uliassi, Laura Guidotti, et al.
European Journal of Medicinal Chemistry (2016) Vol. 127, pp. 250-262
Closed Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
Viktoriya Ivasiv, Claudia Albertini, Ana Elisa Gonçalves, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 19, pp. 1694-1711
Closed Access | Times Cited: 268
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Junting Zhou, Xueyang Jiang, Siyu He, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 20, pp. 8881-8914
Closed Access | Times Cited: 235
Management of oxidative stress and other pathologies in Alzheimer’s disease
Miriama Šimunková, Saleh Alwasel, Ibrahim M. Alhazza, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 9, pp. 2491-2513
Open Access | Times Cited: 230
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress
Zhipei Sang, Keren Wang, Jianghong Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114464-114464
Closed Access | Times Cited: 88
Advancements in the development of multi-target directed ligands for the treatment of Alzheimer’s disease
Naveen Kumar, Vijay Kumar, Piyush Anand, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 61, pp. 116742-116742
Closed Access | Times Cited: 70
Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
Palanivel Ganesan, Prakash Ramalingam, Govindarajan Karthivashan, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 1569-1583
Open Access | Times Cited: 149
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018)
Pankaj Mishra, Amit Kumar, Gautam Panda
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 6, pp. 895-930
Closed Access | Times Cited: 116
Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer’s Disease
Huan Wang, Haiyan Zhang
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 2, pp. 852-862
Closed Access | Times Cited: 113
Medicinal chemistry of acridine and its analogues
Parteek Prasher, Mousmee Sharma
MedChemComm (2018) Vol. 9, Iss. 10, pp. 1589-1618
Open Access | Times Cited: 98
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease
Katarina Chalupova, Jan Korábečný, Manuela Bartolini, et al.
European Journal of Medicinal Chemistry (2019) Vol. 168, pp. 491-514
Open Access | Times Cited: 94
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease
Tao Wang, Xiaohuan Liu, Jing Guan, et al.
European Journal of Medicinal Chemistry (2019) Vol. 169, pp. 200-223
Closed Access | Times Cited: 80
Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments
Mateo Rodríguez-Giraldo, Rodrigo E. González-Reyes, Sofía Ramírez-Guerrero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13630-13630
Open Access | Times Cited: 64
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 45
Tacrine-Based Hybrids: Past, Present, and Future
Anna Bubley, Alexander S. Erofeev, Peter Gorelkin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1717-1717
Open Access | Times Cited: 24
Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases
Pablo Peñalver, Efres Belmonte‐Reche, Norma Adán, et al.
European Journal of Medicinal Chemistry (2018) Vol. 146, pp. 123-138
Open Access | Times Cited: 65
An up-to-date overview of computational polypharmacology in modern drug discovery
Rajan Chaudhari, Lon Wolf R. Fong, Zhi Tan, et al.
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 9, pp. 1025-1044
Open Access | Times Cited: 65
The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease
Vendula Hepnarová, Jan Korábečný, Lenka Matoušková, et al.
European Journal of Medicinal Chemistry (2018) Vol. 150, pp. 292-306
Closed Access | Times Cited: 64
Natural products and their derivatives as multifunctional ligands against Alzheimer's disease
Pooja Patil, Ashima Thakur, Abha Sharma, et al.
Drug Development Research (2019) Vol. 81, Iss. 2, pp. 165-183
Closed Access | Times Cited: 59
The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease
Francesco Mesiti, Daniel Chavarria, Alexandra Gaspar, et al.
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111572-111572
Closed Access | Times Cited: 58
Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
Dikshaa Padhi, Thimmaiah Govindaraju
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7088-7105
Closed Access | Times Cited: 33
Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential
Saikat Mitra, Maniza Muni, Nusrat Jahan Shawon, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 28
Design, synthesis and pharmacological evaluation of N -benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates
Flávia Pereira Dias Viegas, Matheus de Freitas Silva, Miguel Divino da Rocha, et al.
European Journal of Medicinal Chemistry (2018) Vol. 147, pp. 48-65
Open Access | Times Cited: 57
Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties
Pei Cai, Siqiang Fang, Huali Yang, et al.
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 161-176
Closed Access | Times Cited: 54
Tacrine hybrids as multi-target-directed ligands in Alzheimer’s disease: influence of chemical structures on biological activities
Małgorzata Girek, Paweł Szymański
Chemical Papers (2018) Vol. 73, Iss. 2, pp. 269-289
Open Access | Times Cited: 52
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease
David Vicente-Zurdo, Noelia Rosales‐Conrado, María Eugenia León‐González, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1510-1510
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top